Literature DB >> 10893063

Increased cystatin C immunoreactivity in the skin in amyotrophic lateral sclerosis.

S Ono1, N Shimizu, T Imai, A Mihori, K Nagao.   

Abstract

OBJECTIVES: Several abnormalities of skin have been described in patients with amyotrophic lateral sclerosis (ALS). Bunina bodies, which are small eosinophilic intraneuronal inclusions in the remaining lower motor neurons in ALS, are the only pathologically specific hallmark of ALS. It has been demonstrated that Bunina bodies were positive for anti-cystatin C serum. However, cystatin C in the skin of ALS has not been investigated.
MATERIAL AND METHODS: We studied cystatin C immunoreactivity of skin in ALS patients, and the results were compared with those of control subjects.
RESULTS: The epidermis of ALS was immunohistochemically strongly positive for cystatin C as compared with that of controls. The optical density of cystatin C immunostaining reactivity in ALS patients was significantly higher than in controls, and was significantly increased with duration of illness.
CONCLUSION: These data suggest that a metabolic alteration of cystatin C may take place in the skin of ALS and the increased cystatin C in skin is likely to be related to the disease process in ALS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893063     DOI: 10.1034/j.1600-0404.2000.102001047.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Emotional responding in amyotrophic lateral sclerosis.

Authors:  Dorothée Lulé; Anja Kurt; Reinhart Jürgens; Jan Kassubek; Volker Diekmann; Eduard Kraft; Nicola Neumann; Albert C Ludolph; Niels Birbaumer; Silke Anders
Journal:  J Neurol       Date:  2005-06-24       Impact factor: 4.849

2.  Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Authors:  Yuting Ren; Wenjia Zhu; Fang Cui; Fei Yang; Zhaohui Chen; Li Ling; Xusheng Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic.

Authors:  Nils von Neuhoff; Tonio Oumeraci; Thomas Wolf; Katja Kollewe; Peter Bewerunge; Boris Neumann; Benedikt Brors; Johannes Bufler; Ulrich Wurster; Brigitte Schlegelberger; Reinhard Dengler; Marc Zapatka; Susanne Petri
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.